Motivational interviewing for medication adherence

Salvo, Marissa C.; Cannon-Breland, Michelle L.

doi:10.1331/japha.2015.15532

Cited by 42 publications

(16 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Pharmacists play strategic role to recognize and to address these medications-related barriers commonly associated with iron chelators. Addressing these concerns may require a more in-depth, nonconfrontational and collaborative approach, such as through motivational interviewing (34,35), while supporting efforts to enhance patient's perceived self-efficacy on symptoms management.…”

Section: Discussionmentioning

confidence: 99%

Patient Perspective on Iron Chelation Therapy: Barriers and Facilitators of Medication Adherence

Chong

Redzuan

Sathar

et al. 2021

Journal of Patient Experience

View full text Add to dashboard Cite

Nonadherence to iron chelation therapy (ICT) remains a long-standing and serious issue in thalassemia, especially in resource-constrained developing countries. Barriers and facilitators of adherence to ICT in transfusion-dependent thalassemia (TDT) adult patients in Malaysia are not completely understood. This qualitative study explored factors affecting adherence to ICT among TDT adult patients at a public tertiary hospital in Malaysia. Data were collected through 21 semistructured in-depth interviews conducted among purposively sampled patients using a pretested interview guide. All interviews were audio-recorded and transcribed verbatim. Data were analyzed manually using thematic analysis method and managed using Atlas.Ti software. The most frequently discussed subthemes of barriers to adherence included patient-related factors, medications-related factors, sociocultural-related factors, environmental context and resources, and patient–health care provider relationship factors. The facilitators to adherence included having insights of their illness, prevailing sources of motivation emphasizing on strong self-efficacy, low medication burden, and having enabling environment. This study has identified barriers and facilitators that are unique to Malaysian thalassemic adults related to medication adherence. Options for future multifaceted interventions are suggested.

show abstract

Section: Discussionmentioning

confidence: 99%

Patient Perspective on Iron Chelation Therapy: Barriers and Facilitators of Medication Adherence

Chong

Redzuan

Sathar

et al. 2021

Journal of Patient Experience

View full text Add to dashboard Cite

show abstract

“…Significant challenges can thus be encountered when counselling patients from different ethnic backgrounds. While this process routinely does and should include interpreters, motivational interviewing, leaflets, and audio-visual aids where appropriate [15,16], effective counselling may also require healthcare workers to gain deeper insights into different cultures that may be pertinent to their locality. This may encourage considerate dialogue, indeed patients who feel their beliefs are overlooked are more likely to reject therapy [17].…”

Section: Discussionmentioning

confidence: 99%

An Ethnic Variation in the Acceptance of Biological Disease-Modifying Therapies: A University Hospital Experience

Selvaskandan¹,

Moorthy²

2021

Cureus

View full text Add to dashboard Cite

Ethnic variations in the outcomes of rheumatological diseases are well documented. While physiological differences may account for these disparities, attitude to treatment is also likely to be a significant modifiable contributor. We sought to determine if an ethnic variation exists in the uptake of biological disease-modifying anti-rheumatic drugs (DMARD) among a multi-ethnic cohort when offered in-person through a healthcare system free at the point of access. We conducted a retrospective cross-sectional study of patients seen in a biologic therapy counselling clinic between December 2016 and April 2017. Clinic letters from consultations were reviewed, and data including ethnicity, language spoken, and decision to accept or reject the therapy were extracted. We chose to measure uptake over adherence, as we believe it is an earlier, more direct marker of attitudes to joint saving medications. Ninety-one cases were included in the analysis. Over 13.2% (12/91) of the cohort declined a biologic treatment when it was offered as the standard of care for joint disease. Non-Caucasian patients accepted treatment less often than Caucasian (White British) patients (OR 0.265, CI 0.73-0.959, p = 0.043), as did those who did not speak English as a first language (OR 0.094, CI 0.18-0.497, p = 0.005). Age, sex, and diagnosis were well matched between those who accepted and declined therapy. We demonstrate a disparity in the uptake of biologic therapies between the White British population and patients from other ethnicities. The reasons for this are likely multifactorial and could be related to socio-economic factors, language barriers, and cultural differences. Addressing this discrepancy is a crucial first step to tackling preventable disparities in the outcomes of rheumatological disease between different ethnicities.

show abstract

“…Pharmacists are accessible healthcare professionals who are positioned to identify patient nonadherence and can use the techniques of MI in any patient care setting, including the community pharmacy. Pharmacists who use MI can discuss the patient's understanding of their disease and medications, determine how the treatment plan includes patient goals, and engage the patient in communication about any resistance to the plan (Salvo & Cannon-Breland, 2015). In the past, pharmacists gave advice to patients based upon specific questions asked with drug or dosing information.…”

Section: Motivational Interviewing (Mi)mentioning

confidence: 99%

Pharmacy Services in Behavioral Health

Ott

2019

Foundations of Behavioral Health

View full text Add to dashboard Cite

Motivational interviewing for medication adherence

Cited by 42 publications

References 13 publications

Patient Perspective on Iron Chelation Therapy: Barriers and Facilitators of Medication Adherence

Patient Perspective on Iron Chelation Therapy: Barriers and Facilitators of Medication Adherence

An Ethnic Variation in the Acceptance of Biological Disease-Modifying Therapies: A University Hospital Experience

Pharmacy Services in Behavioral Health

Contact Info

Product

Resources

About